Dogwood Therapeutics Inc. Common Stock (DWTX)
Stock · NASDAQ · Health Care
$2.65as of 8/28/2026
Price chart
Open in TradingViewAbout DWTX
Dogwood Therapeutics, Inc., a development-stage biotechnology company, focuses on the development of medicine to treat pain and fatigue-related disorders. Its lead product candidates include IMC-1, a combination of famciclovir and celecoxib that has completed Phase 2b clinical trial to treat fibromyalgia; Halneuron, which is in Phase 2b clinical trial for the treatment of chemotherapy-induced neuropathic pain and can…
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Employees
- 8
- Website
- dwtx.com/
Fundamentals
- 1-day range
- $2.36$2.69
- Market cap
- $57.51M
- P/E (trailing)
- 1.84
- P/E (forward)
- -0.42
- EPS (trailing)
- $-10.60
- Dividend yield
- —
- Beta
- 1.89
- Avg. volume
- 76.5K
52-week range
$1.28$9.5
Next earnings: May 14, 2026 · EPS estimate $-0.20confirmed
Forecasts
3 analyst ratings
Buy 88%
Hold 13%
Sell 0%
1-year price forecast
High
$15
+466.0%
Median
$15
+466.0%
Low
$12
+352.8%
Dogwood Therapeutics Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- DWTXDogwood Therapeutics Inc. Common Stock$2.6▲ 12.07%Market cap $57.51MP/E 1.84$1.28$9.5
- BOLDBoundless Bio Inc. Common Stock$2.83▼ 1.05%Market cap $57.73MP/E —$0.9612$3.16
- CTORCitius Oncology Inc. Common Stock$0.776▼ 1.77%Market cap $58.15MP/E —$0.491$2.25
- DOMHDominari Holdings Inc. Common Stock$2.39▼ 4.02%Market cap $58.34MP/E —$2.19$8.4
- IMMPImmutep Limited American Depositary Shares$0.3848▲ 1.26%Market cap $55.99MP/E —$0.028$0.47
- XLOXilio Therapeutics Inc. Common Stock$9▼ 0.22%Market cap $59.51MP/E —$6.47$12.74
- ANVSAnnovis Bio Inc. Common Stock$1.72▼ 4.97%Market cap $59.59MP/E —$1.54$5.5
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| DWTX Dogwood Therapeutics Inc. Common Stock | $57.51M | 1.84 | $2.6 | ▲ 12.07% | $1.28$9.5 |
| BOLD Boundless Bio Inc. Common Stock | $57.73M | — | $2.83 | ▼ 1.05% | $0.9612$3.16 |
| CTOR Citius Oncology Inc. Common Stock | $58.15M | — | $0.776 | ▼ 1.77% | $0.491$2.25 |
| DOMH Dominari Holdings Inc. Common Stock | $58.34M | — | $2.39 | ▼ 4.02% | $2.19$8.4 |
| IMMP Immutep Limited American Depositary Shares | $55.99M | — | $0.3848 | ▲ 1.26% | $0.028$0.47 |
| XLO Xilio Therapeutics Inc. Common Stock | $59.51M | — | $9 | ▼ 0.22% | $6.47$12.74 |
| ANVS Annovis Bio Inc. Common Stock | $59.59M | — | $1.72 | ▼ 4.97% | $1.54$5.5 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
Insider Activity
Insider Actions →Acquired
611.1K
Disposed
0
- Whitley Richard James · June 16, 2026 · Grant16.8K
- Thomas John C · June 16, 2026 · Grant16.8K
- Gregory Scott Duncan · March 5, 2026 · Grant330.0K
- Gendreau Roger Michael · March 5, 2026 · Grant82.5K
- Grosswald Ralph · March 5, 2026 · Grant82.5K
- Walsh Angela · March 5, 2026 · Grant82.5K
Institutional Ownership
March 31, 2026
- Total shares held
- 3.56M
- Total value held
- $7.51M
- Institutional holders
- 12
Top holders this quarter
- Unknown3.28M
- Unknown132.2K
- Unknown79.4K
- Unknown23.8K
- Unknown14.6K
- Unknown11.8K
- Unknown8.1K
- Unknown7.1K
- Unknown120
- Unknown30
See the full, filterable feed with live charts on the MarketWall dashboard.